Integer Expands Global Presence, Announces Acquisition in Israel

PLANO, Texas, Feb. 19, 2020 (GLOBE NEWSWIRE) — Integer Holdings Corporation (“Integer”) (NYSE: ITGR), a leading medical device outsource manufacturer, today announced it has acquired Inomec, formally establishing its presence in Israel. The acquisition enables Integer to create a research and development and sales center in the region, and adds important catheter design, clinical, and pilot manufacturing capabilities to its extensive portfolio, further positioning the company as a partner of choice for innovative medical technologies.

“Acquiring Inomec strengthens our research and development pipeline by adding differentiated capabilities and expanding our global footprint in a key market with an extensive innovation ecosystem that is widely recognized as a leader in MedTech innovation.” said Joe Dziedzic, Integer president and CEO.

Founded in 2008, Inomec specializes in the research, development and manufacturing of medical devices, including minimally invasive tools, delivery systems, metal implants, drug-device combination devices, and laser processing services. Capabilities include clinical and pilot manufacturing, clean room assembly and packaging services, polymer and metallic laser welding, and bio-compatible 3D printing.

“Expanding our capabilities closer to our customers in Israel, an important region for medical device innovation, will allow us to more effectively enable our customers’ innovation processes and accelerate new product development,” said Payman Khales, president of Integer’s Cardio & Vascular business.

“Integer’s leadership as a medical device outsource manufacturer is unmatched and we look forward to providing our customers increased opportunities with our combined capabilities,” said Sefi Shachrur, Inomec founder and CEO.

Israel (Inomec) will become an important research and development center, in addition to Plymouth, Minn., Chaska, Minn., Clarence, N.Y., Beaverton, Ore., Raynham, Mass., Montevideo, Uruguay, and Galway, Ireland. This new center will enable Integer to be surrounded by an extensive pipeline of early and late stage startups as well as multinational medtech companies located in Israel, while providing added research and development capabilities to feed Integer’s other manufacturing facilities globally.

About Integer^®